Indeed, it has been reported that during cachexia, both cancer patients and mouse models, experience a decrease in the circulating levels of the anabolic factor insulin-like growth factor-1 (IGF-1) and the development of insulin resistance.37, 38, 39, 40, 41, 42, 43. Here, IGF1 is linked to Cachexia.